Covid19

Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed …

As of week 45 2022, six vaccines (Comirnaty, Spikevax Vaxzevria, Jcovden (previously COVID-19 Vaccine Janssen), Valneva and Nuvaxovid) have been …

Read more at www.ecdc.europa.eu

Show More

Related Articles

Back to top button